CBX-12266

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameCBX-12266

Drug Alias NameCBX-12266

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-1 beta inhibitors

TargetsInterleukin-1 beta

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCiblex

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCiblex

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A